1. Home
  2. CPRX
  3. CPRX News

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on October 27, 2025

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

10 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After $200 Million Share Buyback Announcement
CPRX

Simply Wall St.

21 days ago

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After $200 Million Share Buyback Announcement

Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
CPRX

GlobeNewswire

25 days ago

Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
CPRX

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

CPRX

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Premarket Wednesday

CPRX

MT Newswires

a month ago

Catalyst Pharmaceuticals Approves $200 Million Share Repurchase Program

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
CPRX

Zacks

4 months ago

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CPRX

Argus Research

4 months ago

CPRX: Lowering target price to $23.00

CPRX vs. NBIX: Which Stock Is the Better Value Option?
CPRX

Zacks

4 months ago

CPRX vs. NBIX: Which Stock Is the Better Value Option?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

4 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth
CPRX

Simply Wall St.

4 months ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
CPRX

Zacks

4 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

CPRX

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 06/11/2025

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $28.00

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?
CPRX

Zacks

5 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?

Kymera Therapeutics Stock Earns 92 RS Rating
CPRX

Investor's Business Daily

5 months ago

Kymera Therapeutics Stock Earns 92 RS Rating

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?
CPRX

Zacks

5 months ago

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

5 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?
CPRX

Zacks

5 months ago

What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?

If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
CPRX

Zacks

5 months ago

If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer
CPRX

Simply Wall St.

5 months ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer

CPRX or NBIX: Which Is the Better Value Stock Right Now?
CPRX

Zacks

5 months ago

CPRX or NBIX: Which Is the Better Value Stock Right Now?

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
CPRX

Zacks

5 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term

Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?
CPRX

Zacks

5 months ago

Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
CPRX

Zacks

5 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
CPRX

Zacks

5 months ago

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $26.00

The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business
CPRX

Simply Wall St.

5 months ago

The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $25.00

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
CPRX

GuruFocus.com

6 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, Catalyst (CPRX) Q1 Earnings: A Look at Key Metrics
CPRX

Zacks

6 months ago

Compared to Estimates, Catalyst (CPRX) Q1 Earnings: A Look at Key Metrics

Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
CPRX

Zacks

6 months ago

Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates

CPRX

Associated Press Finance

6 months ago

Catalyst: Q1 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings
CPRX

GuruFocus.com

6 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

6 months ago

CPRX: Lowering target price to $24.00

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know
CPRX

Zacks

6 months ago

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?
CPRX

Zacks

6 months ago

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?
CPRX

Simply Wall St.

6 months ago

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now
CPRX

Insider Monkey

6 months ago

Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now

CPRX

Argus Research

6 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

CPRX

Argus Research

6 months ago

CPRX: Raising target price to $24.00

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?
CPRX

Insider Monkey

7 months ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?
CPRX

Zacks

7 months ago

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip
CPRX

Simply Wall St.

7 months ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip

CPRX

Argus Research

7 months ago

CPRX: Lowering target price to $22.00

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade
CPRX

Investor's Business Daily

7 months ago

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
CPRX

GlobeNewswire

7 months ago

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?
CPRX

Insider Monkey

7 months ago

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?

CPRX

Argus Research

7 months ago

CPRX: Lowering target price to $25.00

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?
CPRX

Zacks

7 months ago

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win
CPRX

Investor's Business Daily

7 months ago

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’
CPRX

Insider Monkey

7 months ago

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

CPRX

Argus Research

7 months ago

CPRX: Raising target price to $27.00

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business
CPRX

Simply Wall St.

7 months ago

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
CPRX

Zacks

7 months ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

7 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?
CPRX

Insider Monkey

7 months ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative
CPRX

Simply Wall St.

8 months ago

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

CPRX

Argus Research

8 months ago

CPRX: Raising target price to $24.00

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
CPRX

GlobeNewswire

8 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
CPRX

Simply Wall St.

8 months ago

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
CPRX

GuruFocus.com

8 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
CPRX

Motley Fool

8 months ago

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
CPRX

Zacks

8 months ago

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
CPRX

Zacks

8 months ago

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

CPRX

Associated Press Finance

8 months ago

Catalyst: Q4 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
CPRX

GlobeNewswire

8 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings
CPRX

GuruFocus.com

8 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

8 months ago

CPRX: Rating increased to a BUY

CPRX

Argus Research

8 months ago

CPRX: What does Argus have to say about CPRX?

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90
CPRX

Investor's Business Daily

8 months ago

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

Incyte Stock Sees Relative Strength Rating Rise To 71
CPRX

Investor's Business Daily

8 months ago

Incyte Stock Sees Relative Strength Rating Rise To 71

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%
CPRX

Simply Wall St.

8 months ago

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
CPRX

GlobeNewswire

8 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

CPRX

Argus Research

9 months ago

CPRX: What does Argus have to say about CPRX?

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry
CPRX

Investor's Business Daily

9 months ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Harmony Biosciences Stock Scores 80-Plus RS Rating
CPRX

Investor's Business Daily

9 months ago

Harmony Biosciences Stock Scores 80-Plus RS Rating

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

9 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

9 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

9 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
CPRX

Zacks

9 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

CPRX

Argus Research

9 months ago

CPRX: Raising target price to $24.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

9 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
CPRX

GlobeNewswire

9 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

BeiGene Stock Meets 80-Plus RS Rating Benchmark
CPRX

Investor's Business Daily

9 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

CPRX

Argus Research

9 months ago

CPRX: Raising target price to $23.00

BridgeBio Pharma Stock Earns 87 RS Rating
CPRX

Investor's Business Daily

9 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
CPRX

Zacks

10 months ago

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
CPRX

Investor's Business Daily

10 months ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
CPRX

GlobeNewswire

10 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

10 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
CPRX

Zacks

10 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Arcellx Stock Earns 82 Relative Strength Rating
CPRX

Investor's Business Daily

10 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Neurocrine Biosciences Stock Sees RS Rating Upgrade
CPRX

Investor's Business Daily

10 months ago

Neurocrine Biosciences Stock Sees RS Rating Upgrade

Share on Social Networks: